Glucose-dependent stimulatory effect of glucagon-like peptide 1(7-36) amide on the electrical activity of pancreatic β-cells recorded in vivo

Diabetes

Volumn 48, Issue 4, 1999, Pages 754-757

  Fernandez, Juana ^a   Valdeolmillos, Miguel ^a  

^a INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCOSE; INSULIN; TOLBUTAMIDE;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; ELECTRIC ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERPOLARIZATION; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MOUSE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0032994663     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.4.754     Document Type: Article

References (33)

1. Creutzfeld W, Ebert R: New developments in the incretin concept. Diabetologia 28:565-573, 1985
2. Orskov C: Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 35:701-711, 1992
3. Drucker DJ: Glucagon-like peptides. Diabetes 47:159-169, 1998
4. Kreymann B, Yiangon Y, Kanse S, Willliams G, Ghatei MA, Bloom SR: Isolation and characterization of GLP-1 7-36 amide from rat intestine. FEBS Lett 242:167-170, 1988
5. Orskow C, Bersani M, Johnsen AH, Hojrup P, Holst JJ: Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J Biol Chem 264:12826-12829, 1989
6. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S: Antidiabetogenic effect of GLP-I (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322, 1992
7. Nathan DM, Schreiber E, Fogel H, Mojsov S, Habener JF: Insulinotropic actions of glucagonlike peptide-I-(7-37) in diabetic and non-diabetic subjects. Diabetes Care 15:270-276, 1992
8. Weir GC, Mosjov S, Hendrick GK, Habener JF: Glucagon like peptide 1 (7-37) actions on endocrine pancreas. Diabetes 38:338-342, 1989
9. Komatsu R, Matsuyama T, Namba M, Watanabe N, Itoh H, Kono N, Tarui S: Glucagonostatic and insulinotropic action of glucagon-like peptide-I (7-36)amide. Diabetes 38:902-905, 1989
10. Shima K, Hirota M, Ohboshi C: Effect of glucagon-like peptide-I on insulin secretion. Regul Pept 22:245-252, 1989
11. Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF: Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-transcriptional processing. J Biol Chem 261:11880-11889, 1986
12. Holst JJ, Orskov C, Nielsen OV, Schwartz TW: Truncated glucagon-like peptide-I, an insulin-releasing hormone from the distal gut. FEBS Lett 211:169-174, 1987
13. Orskov C, Holst JJ, Poulsen SS, Kirkegaard P: Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30:874-881, 1987
14. Orskov C, Poulsen SS: Glucagonlike peptide-I-(7-36)-amide receptors only in islets of Langerhans. Diabetes 40:1292-1296, 1991
15. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F: Expression and functional activity of glucagon, GLP-I and glucose-dependent insulinotropic peptide receptors in rat pancreatic islets cells. Diabetes 45:257-261, 1996
16. Göke R, Oltmer B, Sheikh SP, Göke B: Solubilization of active GLP-I (7-36) amide receptors from RINm5F plasma membranes. FEBS Lett 300:232-236, 1992
17. D'Alessio DA, Prigeon RL, Ensick JW: Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes: a physiological role of glucagon-like peptide-I. Diabetes 44: 1433-1437, 1995
18. Drucker DJ, Philippe J, Mojsov S, Chick W, Habener JF: Glucagon-like peptide 1 stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A 84:3434-3438, 1987
19. Suga S, Kanno T, Nakano K, Takeo T, Dobashi Y, Wakui M: GLP-1(7-36) amide augments Ba2+ current through L-type Ca2+ channel in rat pancreatic β-cell in a cAMP-dependent manner. Diabetes 46:1755-1760, 1997
20. ATP current in intact mouse pancreatic β-cells. Biochem Biophys Res Commun 207:33-39, 1995
21. Gromada J, Dissing S, Bokvist K, Rënstrom E, Frokjaer-Jensen J, Wulff BS, Rorsman P: GLP-I increases cytoplasmic calcium in insulin secreting βTC3-cells by enhancement of intracellular calcium mobilization. Diabetes 44:767-774, 1995
22. Lu M, Wheeler M, Leng X, Boyd A: The role of the free cytosolic calcium level in β-cell signal transduction by GIP and GLP-I (7-37). Endocrinology 132:94-100, 1993
23. +2 channel activity. Endocrinology 133:1685-1692, 1993
24. Holz G, Kühtreiber WM, Habener JF: Pancreatic β-cells are rendered glucose-competent by the insulinotropic hormone GLP-I (7-37). Nature 361:362-365, 1993
25. Ämälä C, Aschroft FM, Rorsman P: Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells. Nature 363:356-358, 1993
26. Ashcroft F, Rorsman P: Electrophysiology of the pancreatic β-cell. Prog Biophys Mol Biol 54:87-143, 1991
27. 1 oscillations due to bursting electrical activity in single pancreatic islets. Pflügers Arch 418:417-422, 1991
28. 2+ as evidenced in single pancreatic islets. J Biol Chem 268:22265-22268, 1993
29. Sanchez-Andres JV, Gomis A, Valdeolmillos M: The electrical activity of pancreatic β-cells recorded "in vivo" shows glucose-dependent oscillations. J Physiol 486:223-228, 1995
30. Gomis A, Valdeolmillos M: Regulation by tolbutamide and diazoxide of the electrical activity in mouse pancreatic β-cells recorded in vivo. Br J Pharmacol 123:443-448, 1998
31. Salomon D, Meda P: Heterogeneity and contact-dependent regulation of hormone secretion by individual β-cells. Exp Cell Res 162:507-520, 1986
32. Pipeleers DG: Heterogeneity in pancreatic β-cell population. Diabetes 41:777-781, 1992
33. Valdeolmillos M, Gomis A. Sánchez-Andrés JV: In vivo synchronous membrane potential oscillations in mouse pancreatic β-cells: lack of electrical coordination between islets. J Physiol 493:9-18, 1996